Microbiotix Revenue and Competitors

Location

N/A

Total Funding

Fintech

Industry

Estimated Revenue & Valuation

  • Microbiotix's estimated annual revenue is currently $2M per year.(i)
  • Microbiotix's estimated revenue per employee is $91,000

Employee Data

  • Microbiotix has 22 Employees.(i)
  • Microbiotix grew their employee count by -33% last year.

Microbiotix's People

NameTitleEmail/Phone
1
CEO/President Reveal Email/Phone
2
Chief Business OfficerReveal Email/Phone
3
Head ChemistryReveal Email/Phone
4
Director PharmacologyReveal Email/Phone
5
Director OperationsReveal Email/Phone
6
Research ScientistReveal Email/Phone
7
Lead ScientistReveal Email/Phone
8
Group LeaderReveal Email/Phone
9
Senior ScientistReveal Email/Phone
10
Graduate ResearcherReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.8M27-4%$15.7MN/A
#2
$25.5M178-3%N/AN/A
#3
$1.4M22-50%$21.2MN/A
#4
$56.6M34819%$6MN/A
#5
$6.3M56-21%$216.8MN/A
#6
$0M20%$33.3MN/A
#7
$33.3M2330%N/AN/A
#8
$32.4M232-26%$64.6MN/A
#9
$30M215-22%$46.8MN/A
#10
$261.6M140715%$75MN/A
Add Company

What Is Microbiotix?

Microbiotix is a privately-held, clinical stage biopharmaceutical company engaged in the discovery and development of novel small molecule anti-infective drugs. The Company's clinical programs are focused on hepatitis C virus (HCV) and cytomegalovirus (CMV).

keywords:N/A

N/A

Total Funding

22

Number of Employees

$2M

Revenue (est)

-33%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Microbiotix News

2022-04-19 - Botulism Illness Drugs Market Size 2022-2030| Key Players ...

Eisai; Microbiotix … Botulism Illness Drugs Market Breakdown by Type: Antibiotics; Antitoxins; Other; Market. Botulism Illness...

2022-04-17 - Global Botulinum Market 2022 Key Drivers and Analysis by ...

XOMA; AlphaVax; Microbiotix; Molecular Targeting Technologies; Morphotek. It provides granular analysis of the market segments of the Botulinum...

2022-04-13 - The Chlamydia Market Is Anticipated to Grow with a Considerable CAGR In The 7MM During The Study Period (2019-32), Assesses DelveInsight

... QureTechBio, Vault Pharma, Aeterna Zentaris, Melinta Therapeutics, Abera Bioscience, Prokarium, Blue willow Biologics, Microbiotix,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A220%N/A
#2
N/A22-8%N/A
#3
$1.7M22-33%$173M
#4
$2.2M225%N/A
#5
$1.8M22-27%N/A